Century Therapeutics, Inc. (IPSC)
1.50
+0.12
(+8.70%)
USD |
NASDAQ |
Oct 15, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Century Therapeutics Cash from Operations (TTM) : -86.74M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -86.74M |
| March 31, 2026 | -94.50M |
| December 31, 2025 | -103.88M |
| September 30, 2025 | -112.02M |
| June 30, 2025 | -114.77M |
| March 31, 2025 | -114.51M |
| December 31, 2024 | -110.14M |
| September 30, 2024 | -112.14M |
| June 30, 2024 | -97.46M |
| March 31, 2024 | -89.38M |
| December 31, 2023 | -88.57M |
| September 30, 2023 | -85.37M |
| Date | Value |
|---|---|
| June 30, 2023 | -96.09M |
| March 31, 2023 | -102.52M |
| December 31, 2022 | 13.55M |
| September 30, 2022 | 12.11M |
| June 30, 2022 | 12.36M |
| March 31, 2022 | 19.02M |
| December 31, 2021 | -89.79M |
| September 30, 2021 | -80.04M |
| June 30, 2021 | -65.15M |
| March 31, 2021 | -56.56M |
| December 31, 2020 | -41.27M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Tenax Therapeutics, Inc. | -46.03M |
| Exicure, Inc. | -6.704M |
| Absci Corp. | -108.08M |
| Celularity, Inc. | -8.814M |
| Cardio Diagnostics Holdings, Inc. | -5.660M |